Deepak Nitrite Posts 234% Profit Surge, Shares Rally Over 9%
Deepak Nitrite reported a consolidated net profit of ₹398 crore for the July‑September quarter, a 234% rise from ₹119 crore in the same period last year. The Vadodara‑based specialty chemicals maker saw its shares surge as much as 9.41% to an intraday high of ₹1,616.65 on the BSE on Friday, October 30, a day after the earnings announcement. On the NSE, shares climbed 9.38% to hit ₹1,615.
Revenue from operations jumped 62% to ₹3,076 crore, up from ₹1,902 crore a year earlier. The company also highlighted that its Phenolics segment achieved a record EBIT of ₹933 crore in the first half of the current financial year, surpassing the previous full‑year peak EBIT of ₹867 crore in FY22. It plans to deepen integration through upcoming projects, aiming to accrete top line and profitability.
Deepak Nitrite cited agile procurement of inputs and deep integration of facilities with backward and forward integration as key drivers of its record‑breaking performance amid a difficult operating landscape. The company said it navigated a sharply volatile global environment marked by geopolitical tensions, disrupted trade flows, feedstock constraints and elevated logistics costs, while capitalising on emerging market opportunities.
At 11:02 a.m., Deepak Nitrite shares traded 3.39% higher at ₹1,526, outperforming the NIFTY 500 index which was down 0.1%. The intraday rally reflected investor confidence following the robust earnings and operational highlights presented in the investor presentation. It highlighted its integrated manufacturing capabilities, large domestic production base, operational flexibility and proactive commercial strategies, noting a growing preference for dependable local suppliers, especially in import‑dependent product categories, which further reinforced the relevance of its manufacturing footprint and customer relationships.
The July‑September earnings underscore Deepak Nitrite’s ability to deliver strong growth despite global headwinds. With a 62% revenue rise, 207% EBITDA jump, and record EBIT in its Phenolics segment, the company is positioned to leverage upcoming integration projects to sustain top‑line and profitability growth. Investors will likely monitor how the firm capitalises on its domestic manufacturing strength amid ongoing supply chain uncertainties.